🔎 Trials Near Me

Domov › Crohnova bolezen › Texas › San Antonio

Klinične študije za Crohnova bolezen v San Antonio, TX

15 študij za Crohnova bolezen išče udeležence na lokacijah v San Antonio in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Vključevanje udeležencevFaza 2
  • Southern Star Research Institute /ID# 280822, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07697456

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Vključevanje udeležencevFaza 3
  • Southern Star Research Institute ( Site 0299), San Antonio
Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Vključevanje udeležencevFaza 3
  • Southern Star Research Institute ( Site 5000), San Antonio
Starost 16–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Vključevanje udeležencevFaza 2
  • Sun Research Institute /ID# 266723, San Antonio
  • Southern Star Research Institute /ID# 278124, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2
  • Southern Star Research Institute, LLC, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Gastroenterology Research of America, LLC, San Antonio
  • Southern Star Research Institute, LLC, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2/3
  • Southern Star Research Institute, LLC, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184944

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Vključevanje udeležencevFaza 2
  • Southern Star Research Institute, San Antonio
Starost 18–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07483099

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Vključevanje udeležencevFaza 2
  • Southern Star Research Institute, San Antonio
Starost 18–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Vključevanje udeležencevFaza 4
  • Gastroenterology Research of San Antonio, LLC, San Antonio
  • Southern Star Research Institute, LLC., San Antonio
Starost 18–70 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06045754

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Vključevanje udeležencevFaza 3
  • Southern Star Research Institute, LLC, San Antonio
Starost 18–65 · Vsi spoli · Posodobljeno 27. maj 2026 · NCT06227910

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2
  • Southern Star Research Institute, LLC, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 27. apr. 2026 · NCT06456593

Študije za Crohnova bolezen v drugih mestih

Druge študije v San Antonio

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.